Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
CA 2800237 C · Owner: The Scripps Research Institute · Inventors: Razavi, Hossein; Powers, Evan T.; Kelly, Jeffery W.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Kinetic stabilization of the native state of transthyretin is an effective mechanism for preventing protein misfolding. Because transthyretin misfolding plays an important role in transthyretin amyloid diseases inhibiting such misfolding can be used as an effective treatment or prophylaxis for such diseases. Treatment methods screening methods, as well as specific transthyretin stabilizing compounds are disclosed.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 19, 2003 and granted May 17, 2016. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 19, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 19, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.